Abstract:Sepsis is the third leading cause of death worldwide and the main cause of mortality in hospitals<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Gotts, J. E. & Matthay, M. A. Sepsis: pathophysiology and clinical management. Br. Med. J. 353, i1585 (2016)." href="#ref-CR1" id="ref-link-section-d3911e509">1</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Torio, C. M. & Andrews, R. M. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011: Statistical Brief #160. in Healthcare Cost and Utilization Project (HCUP) Statistical Briefs (Agency for Health Care Research and Quality, Rockville, MD, USA, 2013)." href="#ref-CR2" id="ref-link-section-d3911e509_1">2</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Liu, V. et al. Hospital deaths in patients with sepsis from 2 independent cohorts. J. Am. Med. Assoc. 312, 90–92 (2014)." href="/articles/s41591-018-0213-5#ref-CR3" id="ref-link-section-d3911e512">3</a></sup>, but the best treatment strategy remains uncertain. In particular, evidence suggests that current practices in the administration of intravenous fluids and vasopressors are suboptimal and likely induce harm in a proportion of patients<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Gotts, J. E. & Matthay, M. A. Sepsis: pathophysiology and clinical management. Br. Med. J. 353, i1585 (2016)." href="/articles/s41591-018-0213-5#ref-CR1" id="ref-link-section-d3911e516">1</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Byrne, L. & Van Haren, F. Fluid resuscitation in human sepsis: time to rewrite history? Ann. Intensive Care 7, 4 (2017)." href="#ref-CR4" id="ref-link-section-d3911e519">4</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Marik, P. E. The demise of early goal-directed therapy for severe sepsis and septic shock. Acta Anaesthesiol. Scand. 59, 561–567 (2015)." href="#ref-CR5" id="ref-link-section-d3911e519_1">5</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Marik, P. & Bellomo, R. A rational approach to fluid therapy in sepsis. Br. J. Anaesth. 116, 339–349 (2016)." href="/articles/s41591-018-0213-5#ref-CR6" id="ref-link-section-d3911e522">6</a></sup>. To tackle this sequential decision-making problem, we developed a reinforcement learning agent, the Artificial Intelligence (AI) Clinician, which extracted implicit knowledge from an amount of patient data that exceeds by many-fold the life-time experience of human clinicians and learned optimal treatment by analyzing a myriad of (mostly suboptimal) treatment decisions. We demonstrate that the value of the AI Clinician’s selected treatment is on average reliably higher than human clinicians. In a large validation cohort independent of the training data, mortality was lowest in patients for whom clinicians’ actual doses matched the AI decisions. Our model provides individualized and clinically interpretable treatment decisions for sepsis that could improve patient outcomes.

Optimal Sepsis Patient Treatment using Human-in-the-loop Artificial Intelligence

The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care

Artificial intelligence can use physiological parameters to optimize treatment strategies and predict clinical deterioration of sepsis in ICU

An Interpretable Machine Learning Model for Accurate Prediction of Sepsis in the ICU

Continuous State-Space Models for Optimal Sepsis Treatment - a Deep Reinforcement Learning Approach

Does the "Artificial Intelligence Clinician" learn optimal treatment strategies for sepsis in intensive care?

The development an artificial intelligence algorithm for early sepsis diagnosis in the intensive care unit

An optimal antibiotic selection framework for Sepsis patients using Artificial Intelligence

Individualized Fluid Administration for Critically Ill Patients with Sepsis with an Interpretable Dynamic Treatment Regimen Model

Improving sepsis prediction in intensive care with SepsisAI: A clinical decision support system with a focus on minimizing false alarms

Learning Optimal Treatment Strategies for Sepsis Using Offline Reinforcement Learning in Continuous Space

Enhancing Patient Selection in Sepsis Clinical Trials Design Through an AI Enrichment Strategy: Algorithm Development and Validation

Prediction of Sepsis Mortality in ICU Patients Using Machine Learning Methods

Rethinking Human-AI Collaboration in Complex Medical Decision Making: A Case Study in Sepsis Diagnosis

DeepAISE -- An End-to-End Development and Deployment of a Recurrent Neural Survival Model for Early Prediction of Sepsis

Deep reinforcement learning extracts the optimal sepsis treatment policy from treatment records

Using Machine Learning Algorithms to predict sepsis and its stages in ICU patients

Artificial Intelligence for Clinical Decision Support in Sepsis

Optimization of sepsis risk assessment for ward patients

Reducing patient mortality, length of stay and readmissions through machine learning-based sepsis prediction in the emergency department, intensive care unit and hospital floor units

Optimizing Medical Treatment for Sepsis in Intensive Care: from Reinforcement Learning to Pre-Trial Evaluation